Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance

Molecular and Cellular Proteomics

Volumn 12, Issue 1, 2013, Pages 132-144

  Masui, Olena ^a   White, Nicole M A ^b,c   DeSouza, Leroi V ^a   Krakovska, Olga ^a   Matta, Ajay ^a   Metias, Shereen ^b   Khalil, Bishoy ^b   Romaschin, Alexander D ^b,c   Honey, R John ^d   Stewart, Robert ^d   Pace, Kenneth ^d   Bjarnason, Georg A ^e   Siu, K W Michael ^a   Yousef, George M ^b,c  

^a YORK UNIVERSITY   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

14 3 3 ZETA DELTA; BIOLOGICAL MARKER; GALECTIN 1; PROFILIN; PROFILIN I; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CHEMICAL LABELING; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY METASTASIS; LIQUID CHROMATOGRAPHY; METASTASIS POTENTIAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ASSAY; QUANTITATIVE PROTEOMICS; SURVIVAL RATE; TANDEM MASS SPECTROMETRY; TISSUE MICROARRAY; WESTERN BLOTTING;

14-3-3 PROTEINS; CARCINOMA, RENAL CELL; CHROMATOGRAPHY, LIQUID; DISEASE PROGRESSION; GALECTIN 1; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROFILINS; PROGNOSIS; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84871877704     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.020701     Document Type: Article

References (99)

1. Hollingsworth, J. M., Miller, D. C., Daignault, S., and Hollenbeck, B. K. (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl. Cancer Inst. 98, 1331-1334 (Pubitemid 44530728)
2. Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L., and Blute, M. L. (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 27, 612-624 (Pubitemid 36514472)
3. Russo, P. (2001) Renal cell carcinoma : clinical features and management. Methods Mol. Med. 53, 3-33
4. Lam, J. S., Shvarts, O., Leppert, J. T., Pantuck, A. J., Figlin, R. A., and Belldegrun, A. S. (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J. Urol. 174, 466-472 (Pubitemid 40981575)
5. Hofmann, H. S., Neef, H., Krohe, K., Andreev, P., and Silber, R. E. (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur. Urol. 48, 77-81 (Pubitemid 40835595)
6. Motzer, R. J., Mazumdar, M., Bacik, J., Berg, W., Amsterdam, A., and Ferrara, J. (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J. Clin. Oncol. 17, 2530-2540 (Pubitemid 29368255)
7. Tsui, K. H., Shvarts, O., Smith, R. B., Figlin, R. A., deKernion, J. B., and Belldegrun, A. (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 163, 1090-1095 (Pubitemid 30169368)
8. Johnson, T. V., Young, A. N., Force, S., and Master, V. A. (2011) C-reactive protein may represent sensitive measure of renal cell carcinoma metastasis. Urol. Nurs. 31, 181-182, 194
9. Dubinski, W., Gabril, M., Iakovlev, V. V., Scorilas, A., Youssef, Y. M., Faragalla, H., Kovacs, K., Rotondo, F., Metias, S., Arsanious, A., Plotkin, A., Girgis, A. H., Streutker, C. J., and Yousef, G. M. (2011) Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Hum. Pathol. 43, 1037-1043
10. Iakovlev, V. V., Gabril, M., Dubinski, W., Scorilas, A., Youssef, Y. M., Faragalla, H., Kovacs, K., Rotondo, F., Metias, S., Arsanious, A., Plotkin, A., Girgis, A. H., Streutker, C. J., and Yousef, G. M. (2012) Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Lab. Invest. 92, 46-56
11. Wuttig, D., Zastrow, S., Fussel, S., Toma, M. I., Meinhardt, M., Kalman, K., Junker, K., Sanjmyatav, J., Boll, K., Hackermuller, J., Rolle, A., Grimm, M. O., and Wirth, M. P. (2011) CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. Int. J. Cancer 131, E693-704
12. Hoffmann, N. E., Sheinin, Y., Lohse, C. M., Parker, A. S., Leibovich, B. C., Jiang, Z., and Kwon, E. D. (2008) External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 112, 1471-1479 (Pubitemid 351441159)
13. Tostain, J., Li, G., Gentil-Perret, A., and Gigante, M. (2010) Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur. J. Cancer 46, 3141-3148
14. Schultz, L., Chaux, A., Albadine, R., Hicks, J., Kim, J. J., De Marzo, A. M., Allaf, M. E., Carducci, M. A., Rodriguez, R., Hammers, H. J., Argani, P., Reuter, V. E., and Netto, G. J. (2011) Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am. J. Surg. Pathol. 35, 1549-1556
15. Arsanious, A., Bjarnason, G. A., and Yousef, G. M. (2009) From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol. Cancer 8, 20
16. Romaschin, A. D., Youssef, Y., Chow, T. F., Siu, K. W., DeSouza, L. V., Honey, R. J., Stewart, R., Pace, K. T., and Yousef, G. M. (2009) Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins. Biol. Chem. 390, 125-135
17. Shi, T., Dong, F., Liou, L. S., Duan, Z. H., Novick, A. C., and DiDonato, J. A. (2004) Differential protein profiling in renal-cell carcinoma. Mol. Carcinog. 40, 47-61 (Pubitemid 38581662)
18. Siu, K. W., DeSouza, L. V., Scorilas, A., Romaschin, A. D., Honey, R. J., Stewart, R., Pace, K., Youssef, Y., Chow, T. F., and Yousef, G. M. (2009) Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J. Proteome. Res. 8, 3797-3807
19. Khella, H. W., White, N. M., Faragalla, H., Gabril, M., Boazak, M., Dorian, D., Khalil, B., Antonios, H., Bao, T. T., Pasic, M. D., Honey, R. J., Stewart, R., Pace, K. T., Bjarnason, G. A., Jewett, M. A., and Yousef, G. M. (2012) Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biol. 33, 131-140
20. White, N. M., Khella, H. W., Grigull, J., Adzovic, S., Youssef, Y. M., Honey, R. J., Stewart, R., Pace, K. T., Bjarnason, G. A., Jewett, M. A., Evans, A. J., Gabril, M., and Yousef, G. M. (2011) miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215. Br. J. Cancer 105, 1741-1749
21. White, N. M., and Yousef, G. M. (2011) Translating molecular signatures of renal cell carcinoma into clinical practice. J. Urol. 186, 9-11
22. Pavlovich, C. P., and Schmidt, L. S. (2004) Searching for the hereditary causes of renal-cell carcinoma. Nat. Rev. Cancer 4, 381-393 (Pubitemid 38579484)
23. Sarto, C., Marocchi, A., Sanchez, J. C., Giannone, D., Frutiger, S., Golaz, O., Wilkins, M. R., Doro, G., Cappellano, F., Hughes, G., Hochstrasser, D. F., and Mocarelli, P. (1997) Renal cell carcinoma and normal kidney protein expression. Electrophoresis 18, 599-604 (Pubitemid 27174453)
24. DeSouza, L. V., Grigull, J., Ghanny, S., Dube, V., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2007) Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics. 6, 1170-1182 (Pubitemid 47099227)
25. DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2005) Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 4, 377-386 (Pubitemid 40548142)
26. Ralhan, R., DeSouza, L. V., Matta, A., Chandra, T. S., Ghanny, S., Datta, G. S., Bahadur, S., and Siu, K. W. (2008) Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol. Cell. Proteomics. 7, 1162-1173 (Pubitemid 351943962)
27. Ralhan, R., Masui, O., DeSouza, L. V., Matta, A., Macha, M., and Siu, K. W. (2011) Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: strategy for discovery of candidate serological biomarkers. Proteomics 11, 2363-2376
28. Shilov, I. V., Seymour, S. L., Patel, A. A., Loboda, A., Tang, W. H., Keating, S. P., Hunter, C. L., Nuwaysir, L. M., and Schaeffer, D. A. (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol. Cell. Proteomics 6, 1638-1655 (Pubitemid 47506173)
29. Tang, W. H., Shilov, I. V., and Seymour, S. L. (2008) Nonlinear fitting method for determining local false discovery rates from decoy database searches. J. Proteome Res. 7, 3661-3667
30. Voisin, S. N., Krakovska, O., Matta, A., DeSouza, L. V., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2011) Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One 6, e16352
31. Wang, N., and Li, L. (2008) Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis. Anal. Chem. 80, 4696-4710 (Pubitemid 351842350)
32. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863-14868 (Pubitemid 29003722)
33. Ito, K., and Ralph, S. J. (2012) Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence. Clin. Exp. Metastasis 29, 561-572
34. Kim, H. J., Jeon, H. K., Cho, Y. J., Park, Y. A., Choi, J. J., Do, I. G., Song, S. Y., Lee, Y. Y., Choi, C. H., Kim, T. J., Bae, D. S., Lee, J. W., and Kim, B. G. (2012) High galectin-1 expression correlates with poor prognosis and is involved in epithelial ovarian cancer proliferation and invasion. Eur. J. Cancer 48, 1914-1921
35. Camby, I., Belot, N., Lefranc, F., Sadeghi, N., de, L. Y., Kaltner, H., Musette, S., Darro, F., Danguy, A., Salmon, I., Gabius, H. J., and Kiss, R. (2002) Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases. J. Neuropathol. Exp. Neurol. 61, 585-596 (Pubitemid 34721463)
36. Lu, J., Guo, H., Treekitkarnmongkol, W., Li, P., Zhang, J., Shi, B., Ling, C., Zhou, X., Chen, T., Chiao, P. J., Feng, X., Seewaldt, V. L., Muller, W. J., Sahin, A., Hung, M. C., and Yu, D. (2009) 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 16, 195-207
37. Moiseeva, E. P., Spring, E. L., Baron, J. H., and de Bono, D. P. (1999) Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix. J. Vasc. Res. 36, 47-58 (Pubitemid 29106806)
38. Pollard, T. D., and Borisy, G. G. (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453-465 (Pubitemid 36263079)
39. Witke, W. (2004) The role of profilin complexes in cell motility and other cellular processes. Trends Cell Biol. 14, 461-469
40. Wu, M. H., Hong, T. M., Cheng, H. W., Pan, S. H., Liang, Y. R., Hong, H. C., Chiang, W. F., Wong, T. Y., Shieh, D. B., Shiau, A. L., Jin, Y. T., and Chen, Y. L. (2009) Galectin-1-mediated tumor invasion and metastasis, upregulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol. Cancer Res. 7, 311-318
41. Zou, L., Hazan, R., and Roy, P. (2009) Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner. Cell Motil. Cytoskeleton 66, 1048-1056
42. Noma, N., Simizu, S., Kambayashi, Y., Kabe, Y., Suematsu, M., and Umezawa, K. (2012) Involvement of NF-kappaB-mediated expression of galectin-3-binding protein in TNF-alpha-induced breast cancer cell adhesion. Oncol. Rep. 27, 2080-2084
43. Fan, C., Fu, Z., Su, Q., Angelini, D. J., Van, E. J., and Johns, R. A. (2011) S100A11 mediates hypoxia-induced mitogenic factor (HIMF)-induced smooth muscle cell migration, vesicular exocytosis, and nuclear activation. Mol. Cell. Proteomics. 10, M110.000901
44. Keshamouni, V. G., Michailidis, G., Grasso, C. S., Anthwal, S., Strahler, J. R., Walker, A., Arenberg, D. A., Reddy, R. C., Akulapalli, S., Thannickal, V. J., Standiford, T. J., Andrews, P. C., and Omenn, G. S. (2006) Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/ invasive phenotype. J. Proteome Res. 5, 1143-1154 (Pubitemid 43727792)
45. Cheng, C. W., Wang, H. W., Chang, C. W., Chu, H. W., Chen, C. Y., Yu, J. C., Chao, J. I., Liu, H. F., Ding, S. L., and Shen, C. Y. (2012) MicroRNA- 30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Res. Treat. 134, 1081-1093
46. Diamandis, M., White, N. M., and Yousef, G. M. (2010) Personalized medicine: marking a new epoch in cancer patient management. Mol. Cancer Res. 8, 1175-1187
47. Yousef, G. M. (2012) Personalized cancer genomics: the road map to clinical implementation. Clin. Chem. 58, 661-663
48. Minamida, S., Iwamura, M., Kodera, Y., Kawashima, Y., Ikeda, M., Okusa, H., Fujita, T., Maeda, T., and Baba, S. (2011) Profilin 1 overexpression in renal cell carcinoma. Int. J. Urol. 18, 63-71
49. Dallmann, K., Junker, H., Balabanov, S., Zimmermann, U., Giebel, J., and Walther, R. (2004) Human agmatinase is diminished in the clear cell type of renal cell carcinoma. Int. J. Cancer 108, 342-347 (Pubitemid 37549598)
50. Hwa, J. S., Park, H. J., Jung, J. H., Kam, S. C., Park, H. C., Kim, C. W., Kang, K. R., Hyun, J. S., and Chung, K. H. (2005) Identification of proteins differentially expressed in the conventional renal cell carcinoma by proteomic analysis. J. Korean Med. Sci. 20, 450-455
51. Xinzhou, H., Ning, Y., Ou, W., Xiaodan, L., Fumin, Y., Huitu, L., and Wei, Z. (2011) RKIp inhibits the migration and invasion of human prostate cancer PC-3M cells through regulation of extracellular matrix. Mol. Biol. (Mosk.) 45, 1004-1011
52. Yang, L. P., Jiang, S., Liu, J. Q., Miao, X. Y., and Yang, Z. L. (2012) Association of immunostaining of galectin-3 and Sambucus nigra agglutinin with invasion, metastasis and poor progression of gallbladder adenocarcinoma. Hepatogastroenterology 59 [Epub ahead of print]
53. Wang, Y. G., Kim, S. J., Baek, J. H., Lee, H. W., Jeong, S. Y., and Chun, K. H. (2012) Galectin-3 increases the motility of mouse melanoma cells by regulating MMP-1 expression. Exp. Mol. Med. 44, 387-93
54. Gillies, R. J., Robey, I., and Gatenby, R. A. (2008) Causes and consequences of increased glucose metabolism of cancers. J. Nucl. Med. 49 Suppl 2, 24S-42S (Pubitemid 351948035)
55. Huang, S. K., Darfler, M. M., Nicholl, M. B., You, J., Bemis, K. G., Tegeler, T. J., Wang, M., Wery, J. P., Chong, K. K., Nguyen, L., Scolyer, R. A., and Hoon, D. S. (2009) LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One 4, e4430
56. Ramaswamy, S., Ross, K. N., Lander, E. S., and Golub, T. R. (2003) A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (Pubitemid 36068681)
57. Moiseeva, E. P., Williams, B., Goodall, A. H., and Samani, N. J. (2003) Galectin-1 interacts with beta-1 subunit of integrin. Biochem. Biophys. Res. Commun. 310, 1010-1016 (Pubitemid 37188723)
58. Camby, I., Decaestecker, C., Lefranc, F., Kaltner, H., Gabius, H. J., and Kiss, R. (2005) Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochem. Biophys. Res. Commun. 335, 27-35 (Pubitemid 41350759)
59. Aitken, A. (2006) 14-3-3 proteins: a historic overview. Semin. Cancer Biol. 16, 162-172
60. Gronborg, M., Kristiansen, T. Z., Iwahori, A., Chang, R., Reddy, R., Sato, N., Molina, H., Jensen, O. N., Hruban, R. H., Goggins, M. G., Maitra, A., and Pandey, A. (2006) Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol. Cell. Proteomics. 5, 157-171 (Pubitemid 43169348)
61. Wu, N., Zhang, W., Yang, Y., Liang, Y. L., Wang, L. Y., Jin, J. W., Cai, X. M., and Zha, X. L. (2006) Profilin 1 obtained by proteomic analysis in all-trans retinoic acid-treated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics 6, 6095-6106 (Pubitemid 44851394)
62. Ma, C. Y., Zhang, C. P., Zhong, L. P., Pan, H. Y., Chen, W. T., Wang, L. Z., Andrew, O. W., Ji, T., and Han, W. (2011) Decreased expression of profilin 2 in oral squamous cell carcinoma and its clinicopathological implications. Oncol. Rep. 26, 813-823
63. Chan, C. M., Wong, S. C., Lam, M. Y., Hui, E. P., Chan, J. K., Lo, E. S., Cheuk, W., Wong, M. C., Tsao, S. W., and Chan, A. T. (2008) Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. Arch. Pathol. Lab. Med. 132, 675-683 (Pubitemid 351489621)
64. Zoidakis, J., Makridakis, M., Zerefos, P. G., Bitsika, V., Esteban, S., Frantzi, M., Stravodimos, K., Anagnou, N. P., Roubelakis, M. G., Sanchez-Carbayo, M., and Vlahou, A. (2012) Profilin 1 is a potential biomarker for bladder cancer aggressiveness. Mol. Cell. Proteomics. 11, M111.009449
65. Kuo, P. L., Huang, M. S., Cheng, D. E., Hung, J. Y., Yang, C. J., and Chou, S. H. (2012) Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparinbinding EGF-like growth factor. J. Biol. Chem. 287, 9753-9764
66. Huang, L., Zheng, M., Zhou, Q. M., Zhang, M. Y., Jia, W. H., Yun, J. P., and Wang, H. Y. (2011) Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma. Cancer 117, 3363-3373
67. Li, Y., Zou, L., Li, Q., Haibe-Kains, B., Tian, R., Li, Y., Desmedt, C., Sotiriou, C., Szallasi, Z., Iglehart, J. D., Richardson, A. L., and Wang, Z. C. (2010) Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat. Med. 16, 214-218
68. Lin, C. C., Chen, L. C., Tseng, V. S., Yan, J. J., Lai, W. W., Su, W. P., Lin, C. H., Huang, C. Y., and Su, W. C. (2011) Malignant pleural effusion cells show aberrant glucose metabolism gene expression. Eur. Respir. J. 37, 1453-1465
69. Hamaguchi, T., Iizuka, N., Tsunedomi, R., Hamamoto, Y., Miyamoto, T., Iida, M., Tokuhisa, Y., Sakamoto, K., Takashima, M., Tamesa, T., and Oka, M. (2008) Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int. J. Oncol. 33, 725-731
70. Tang, Z., Yuan, S., Hu, Y., Zhang, H., Wu, W., Zeng, Z., Yang, J., Yun, J., Xu, R., and Huang, P. (2012) Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester. J. Bioenerg. Biomembr. 44, 117-125
71. Tsutsumi, S., Fukasawa, T., Yamauchi, H., Kato, T., Kigure, W., Morita, H., Asao, T., and Kuwano, H. (2009) Phosphoglucose isomerase enhances colorectal cancer metastasis. Int. J. Oncol. 35, 1117-1121
72. Funasaka, T., Hogan, V., and Raz, A. (2009) Phosphoglucose isomerase/ autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res. 69, 5349-5356
73. Colas, E., Perez, C., Cabrera, S., Pedrola, N., Monge, M., Castellvi, J., Eyzaguirre, F., Gregorio, J., Ruiz, A., Llaurado, M., Rigau, M., Garcia, M., Ertekin, T., Montes, M., Lopez-Lopez, R., Carreras, R., Xercavins, J., Ortega, A., Maes, T., Rosell, E., Doll, A., Abal, M., Reventos, J., and Gil-Moreno, A. (2011) Molecular markers of endometrial carcinoma detected in uterine aspirates. Int. J. Cancer 129, 2435-2444
74. Lovat, P. E., Corazzari, M., Armstrong, J. L., Martin, S., Pagliarini, V., Hill, D., Brown, A. M., Piacentini, M., Birch-Machin, M. A., and Redfern, C. P. (2008) Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress. Cancer Res. 68, 5363-5369
75. Ashrafian, H., O'Flaherty, L., Adam, J., Steeples, V., Chung, Y. L., East, P., Vanharanta, S., Lehtonen, H., Nye, E., Hatipoglu, E., Miranda, M., Howarth, K., Shukla, D., Troy, H., Griffiths, J., Spencer-Dene, B., Yusuf, M., Volpi, E., Maxwell, P. H., Stamp, G., Poulsom, R., Pugh, C. W., Costa, B., Bardella, C., Di Renzo, M. F., Kotlikoff, M. I., Launonen, V., Aaltonen, L., El-Bahrawy, M., Tomlinson, I., and Pollard, P. J. (2010) Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis. Cancer Res. 70, 9153-9165
76. Hao, J., Wang, K., Yue, Y., Tian, T., Xu, A., Hao, J., Xiao, X., and He, D. (2012) Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells. Mol. Cell Biochem. 359, 323-332
77. Meding, S., Balluff, B., Elsner, M., Schone, C., Rauser, S., Nitsche, U., Maak, M., Schafer, A., Hauck, S. M., Ueffing, M., Langer, R., Hofler, H., Friess, H., Rosenberg, R., and Walch, A. (2012) Tissue based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer. J. Pathol. [Epub ahead for print]
78. Thongwatchara, P., Promwikorn, W., Srisomsap, C., Chokchaichamnankit, D., Boonyaphiphat, P., and Thongsuksai, P. (2011) Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol. Rep. 26, 185-191
79. Wang, J. W., Peng, S. Y., Li, J. T., Wang, Y., Zhang, Z. P., Cheng, Y., Cheng, D. Q., Weng, W. H., Wu, X. S., Fei, X. Z., Quan, Z. W., Li, J. Y., Li, S. G., and Liu, Y. B. (2009) Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer Lett. 281, 71-81
80. Hu, L., Lau, S. H., Tzang, C. H., Wen, J. M., Wang, W., Xie, D., Huang, M., Wang, Y., Wu, M. C., Huang, J. F., Zeng, W. F., Sham, J. S., Yang, M., and Guan, X. Y. (2004) Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene 23, 298-302 (Pubitemid 38142264)
81. Lang, S. H., Hyde, C., Reid, I. N., Hitchcock, I. S., Hart, C. A., Bryden, A. A., Villette, J. M., Stower, M. J., and Maitland, N. J. (2002) Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52, 253-263
82. Cao, W., Liu, N., Tang, S., Bao, L., Shen, L., Yuan, H., Zhao, X., and Lu, H. (2008) Acetyl-coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines. Biochim. Biophys. Acta 1780, 873-880
83. Chen, Y. R., Juan, H. F., Huang, H. C., Huang, H. H., Lee, Y. J., Liao, M. Y., Tseng, C. W., Lin, L. L., Chen, J. Y., Wang, M. J., Chen, J. H., and Chen, Y. J. (2006) Quantitative proteomic and genomic profiling reveals metas-tasis- related protein expression patterns in gastric cancer cells. J. Proteome. Res. 5, 2727-2742
84. Ma, Z., Cao, M., Liu, Y., He, Y., Wang, Y., Yang, C., Wang, W., Du, Y., Zhou, M., and Gao, F. (2010) Mitochondrial F1Fo-ATP synthase translocates to cell surface in hepatocytes and has high activity in tumor-like acidic and hypoxic environment. Acta Biochim. Biophys. Sin. (Shanghai) 42, 530-537
85. Xie, H. L., Li, Z. Y., Gan, R. L., Li, X. J., Zhang, Q. L., Hui, M., and Zhou, X. T. (2010) Differential gene and protein expression in primary gastric carcinomas and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. J. Dig. Dis. 11, 167-175
86. Hynninen, P., Parkkila, S., Huhtala, H., Pastorekova, S., Pastorek, J., Waheed, A., Sly, W. S., and Tomas, E. (2012) Carbonic anhydrase isozymes II, IX, and XII in uterine tumors. APMIS 120, 117-129
87. Cheng, I. K., Ching, A. K., Chan, T. C., Chan, A. W., Wong, C. K., Choy, K. W., Kwan, M., Lai, P. B., and Wong, N. (2010) Reduced CRYL1 expression in hepatocellular carcinoma confers cell growth advantages and correlates with adverse patient prognosis. J. Pathol. 220, 348-360
88. Cho-Vega, J. H., Vega, F., Schwartz, M. R., and Prieto, V. G. (2007) Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR. J. Cutan. Pathol. 34, 535-542 (Pubitemid 46920260)
89. Sakakura, C., Takemura, M., Hagiwara, A., Shimomura, K., Miyagawa, K., Nakashima, S., Yoshikawa, T., Takagi, T., Kin, S., Nakase, Y., Fujiyama, J., Hayasizaki, Y., Okazaki, Y., and Yamagishi, H. (2004) Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br. J. Cancer 90, 665-671 (Pubitemid 38297208)
90. Kanamori, T., Nishimaki, K., Asoh, S., Ishibashi, Y., Takata, I., Kuwabara, T., Taira, K., Yamaguchi, H., Sugihara, S., Yamazaki, T., Ihara, Y., Nakano, K., Matuda, S., and Ohta, S. (2003) Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain. EMBO J. 22, 2913-2923 (Pubitemid 36758613)
91. Wang, B., Hsu, S. H., Frankel, W., Ghoshal, K., and Jacob, S. T. (2012) Stat3-mediated activation of miR-23a suppresses gluconeogenesis in hepatocellular carcinoma by downregulating G6PC and PGC-1alpha. Hepatology 56, 186-197
92. Chen, M., Zhang, J., Li, N., Qian, Z., Zhu, M., Li, Q., Zheng, J., Wang, X., and Shi, G. (2011) Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer. PLoS One 6, e25564
93. Hawthorn, L., Luce, J., Stein, L., and Rothschild, J. (2010) Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast. BMC Cancer 10, 460
94. Han, M. J., Wang, H., Beer, L. A., Tang, H. Y., Herlyn, M., and Speicher, D. W. (2010) A systems biology analysis of metastatic melanoma using in-depth three-dimensional protein profiling. Proteomics 10, 4450-4462
95. Ross, C. D., Gomaa, M. A., Gillies, E., Juengel, R., and Medina, J. E. (2000) Tumor grade, microvessel density, and activities of malate dehydrogenase, lactate dehydrogenase, and hexokinase in squamous cell carcinoma. Otolaryngol. Head Neck Surg. 122, 195-200 (Pubitemid 30086138)
96. Chaika, N. V., Yu, F., Purohit, V., Mehla, K., Lazenby, A. J., DiMaio, D., Anderson, J. M., Yeh, J. J., Johnson, K. R., Hollingsworth, M. A., and Singh, P. K. (2012) Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma. PLoS One 7, e32996
97. Wang, L., Liu, H. L., Li, Y., and Yuan, P. (2011) Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat models. World J. Gastroenterol. 17, 1434-1441
98. Yun, J., Frankenberger, C. A., Kuo, W. L., Boelens, M. C., Eves, E. M., Cheng, N., Liang, H., Li, W. H., Ishwaran, H., Minn, A. J., and Rosner, M. R. (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 30, 4500-4514
99. Fan, H. Z., Liu, H., Zhang, C., Gao, D. M., Xue, Q., Chen, J., Sun, R. X., Liu, Y. K., and Yang, P. Y. (2009) Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model. J. Cancer Res. Clin. Oncol. 135, 591-602